CENTOGENE · 3 days ago
Business Development Director EUROPE (m/f/d) – Reproductive Genetics
CENTOGENE is a truly international company focused on advancing diagnostic solutions for patients with rare diseases. They are seeking a highly experienced Business Development Director to lead and expand commercial activities in Reproductive Genetics across Europe, driving revenue growth and developing strategic partnerships.
BiotechnologyClinical TrialsGeneticsHealth CareHealth Diagnostics
Responsibilities
Develop and execute the commercial and business development strategy for Reproductive Genetics in Europe or assigned territories
Drive growth of the reproductive genetics portfolio
Identify, establish, and manage strategic partnerships with IVF clinics, hospitals, laboratories, and key opinion leaders
Lead negotiations and closing of high-value commercial agreements
Analyze market trends, competitive landscape, and customer needs to identify new business opportunities
Collaborate closely with internal teams (medical, marketing, operations, and customer support) to ensure successful implementation of commercial strategies
Represent the company at international congresses, conferences, and industry events
Manage key accounts and ensure high levels of customer satisfaction and long-term collaboration
Prepare commercial forecasts, reports, and performance metrics for senior management
Qualification
Required
Minimum 5 years of experience in business development, sales, or commercial leadership, preferably within genetics, IVF, reproductive medicine, or life sciences
Proven experience managing European markets or multi-country territories
Strong knowledge of Reproductive Genetics, PGT-A, PGT-M, PGT-SR, Carrier Screening
Demonstrated success in building and growing complex B2B partnerships
Excellent negotiation, communication, and presentation skills
High level of scientific and clinical understanding, with the ability to communicate complex concepts clearly to non-technical stakeholders
Fluent English (written and spoken) – mandatory
Full availability to travel extensively across Europe
Preferred
Additional European languages are a strong plus
Benefits
Competitive compensation package, including performance-based incentives
Company
CENTOGENE
CENTOGENE provides methods and technology for human genetics analysis.
Funding
Current Stage
Public CompanyTotal Funding
$224.93MKey Investors
LiferaOxford Finance LLCTVM Capital Life Science
2023-06-28Post Ipo Debt· $30M
2022-02-01Post Ipo Equity· $16.91M
2022-02-01Post Ipo Debt· $45M
Recent News
2025-08-21
Company data provided by crunchbase